Opko Health, Inc.
- Stock
- Ticker OPK
- ISIN US68375N1037
- Nasdaq
Performance, volatility and drawdowns of Opko Health, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $1,504. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −92.7% in 03/2024, measured from the peak in 12/2016. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 184 | 150 | 157 | 56 | 148 | 124 | 164 | 65 |
| Gross profit | 85 | 43 | 49 | 35 | 116 | 46 | 80 | 42 |
| Operating income | -33 | -67 | -60 | -34 | 1.5 | -51 | -7.0 | -31 |
| EBITDA | -9.1 | -44 | -37 | -11 | 24 | -29 | 15 | -12 |
| Net income | 14 | -68 | -148 | 22 | -31 | -55 | -8.4 | -54 |
| Earnings per share | 0.01 | -0.10 | -0.19 | 0.03 | -0.04 | -0.07 | -0.01 | -0.07 |
| Balance sheet | ||||||||
| Total assets | 2,200 | 2,128 | 1,973 | 1,996 | 1,932 | 1,857 | 1,829 | 1,880 |
| Liabilities | 835 | 817 | 676 | 690 | 664 | 652 | 645 | 764 |
| Equity | 1,365 | 1,312 | 1,297 | 1,305 | 1,268 | 1,205 | 1,184 | 1,116 |
| Cash | 427 | 429 | 267 | 412 | 364 | 332 | 301 | 384 |
| Long-term debt | 3.0 | 2.8 | 2.8 | 2.5 | 2.3 | 2.0 | 1.8 | 1.6 |
| Cash flow | ||||||||
| Operating cash flow | -44 | -35 | -83 | -35 | -26 | -19 | -44 | -36 |
| Capital expenditure | -5.4 | -3.2 | -3.3 | -3.1 | -2.7 | -1.8 | -3.0 | -2.8 |
| Free cash flow | -50 | -38 | -87 | -38 | -29 | -21 | -47 | -39 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +168.7%, weakest 2022 at −74.0%. 3 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | −$0.07 |
| 27 Jul 2026 | −$0.01 |
| 28 Apr 2026 | −$0.07 |
| 26 Feb 2026 | −$0.04 |
| 29 Oct 2025 | $0.03 |
| 31 Jul 2025 | −$0.19 |
| 1 May 2025 | −$0.10 |
| 3 Mar 2025 | $0.01 |
| 7 Nov 2024 | $0.03 |
| 7 Aug 2024 | −$0.01 |
| 7 May 2024 | −$0.12 |
| 1 Mar 2024 | −$0.09 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.1bn
- Market cap in trading currency
- $1.17bn
- Enterprise value
- $1.26bn
- P/E
- –
- P/S
- 2.32
- P/B
- 1.04
- EV/Sales
- 2.51
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -11.6%
Results (last four quarters)
- Revenue
- $502m
- Gross profit
- $284m
- EBITDA
- −$1.97m
- Net income
- −$148m
- Earnings per share
- −$0.19
- Revenue per share
- $0.68
- Revenue growth
- +15.9%
- Earnings growth
- −347.5%
Profitability
- Gross margin
- 56.6%
- Operating margin
- -17.5%
- Net margin
- -29.5%
- Return on equity
- -12.2%
- Return on assets
- -7.9%
Balance sheet and cash flow
- Cash
- $384m
- Cash per share
- $0.52
- Financial debt
- $477m
- Debt/equity %
- 43
- Current ratio
- 4.97
- Book value per share
- $1.50
- Operating cash flow
- −$125m
- Free cash flow
- −$135m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 743m
- Volume
- 3.52m
- Avg. volume 3 months
- 3.81m
- Relative volume
- 0.9
Price and technicals
- Price
- $1.57
- 1 day
- −2.5%
- 52-week high
- $1.77
- 52-week low
- $1.10
- Distance to 52-week high
- −11.3%
- Distance to 52-week low
- +42.7%
- Distance to 50-day line
- −2.4%
- Distance to 200-day line
- +14.3%
- RSI (14)
- 43
- Volatility 1M
- 35.3%
Performance
- 1 week
- −6.5%
- 1 month
- −3.7%
- 3 months
- +6.1%
- 6 months
- +23.6%
- YTD
- +24.6%
- 1 year
- +19.8%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has OPK performed since 11/2016?
$10,000 grew to $1,504 by 20 Nov 2026, which is −17.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is OPK?
Volatility was 62.9% per year, measured on monthly returns. The largest decline from a peak was −92.7%, with the low in 03/2024.
How does OPK compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, OPK returned −17.3% at 62.9%. The correlation of monthly returns was 0.38; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.